We are very excited to announce that a recent Chase Away research project has resulted in the development of a new technology which could ultimately help dogs with hemangiosarcoma and other types of cancers.
Canine hemangiosarcoma is a highly aggressive tumor of the blood vessels that is oftentimes fatal. Despite chemotherapy, survival times rarely exceed 6 months, and new approaches to the treatment of this cancer are desperately needed.
